<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Arzerra: EMA stiller supplerende spørgsmål om den bredere label (bendamustine) se side 14 http:&#x2F;&#x2F;www.ema.europa.eu&#x2F;docs&#x2F;en_GB&#x2F;document_library&#x2F;Minutes&#x2F;2014&#x2F;02&#x2F;WC500162067.pdf]]></title><description><![CDATA[<p dir="auto">Arzerra: EMA stiller supplerende spørgsmål om den bredere label (bendamustine) se side 14 <a href="http://www.ema.europa.eu/docs/en_GB/document_library/Minutes/2014/02/WC500162067.pdf" rel="nofollow ugc">http://www.ema.europa.eu/docs/en_GB/document_library/Minutes/2014/02/WC500162067.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/398018/arzerra-ema-stiller-supplerende-sprgsml-om-den-bredere-label-bendamustine-se-side-14-httpwwwemaeuropaeudocsen-gbdocument-libraryminutes201402wc500162067pdf</link><generator>RSS for Node</generator><lastBuildDate>Tue, 09 Jun 2026 07:45:53 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/398018.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 10 Jun 2020 06:17:41 GMT</pubDate><ttl>60</ttl></channel></rss>